Approximately thirty million American women will gain from the new health reform law over the next ten years, according to a new report from The Commonwealth Fund, a private foundation based in New York…
No Comments »
Filed under: Women's Health
WASHINGTON (MedPage Today) — It’s been an unusually hectic July for the FDA, and this past week was no exception. The agency approved a polypill to treat hypertension, and separate FDA advisory committees endorsed an investigational antiplatelet, grappled with safety issues involving a new spine device, and debated when it’s okay to change endpoints in [...]
No Comments »
Filed under: General Health News
ADELPHI, Md. (MedPage Today) — An FDA advisory panel was split this week over whether Pfizer should be allowed to substitute an endpoint in its clinical trial testing sildenafil as a treatment for kids with pulmonary arterial hypertension.
No Comments »
Filed under: General Health News
(MedPage Today) — The FDA has warned consumers not to use a product called Miracle Mineral Solution — which makes broad health claims — because it’s actually an industrial strength bleach.
No Comments »
Filed under: Pharmacy News
Geron Corporation announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron’s Investigational New Drug (IND) application has been lifted and the company’s Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed.
No Comments »
Filed under: Pharmacy News
Biogen Idec (NASDAQ: BIIB) and Swedish Orphan Biovitrum AB (STO: SOBI) announced results from a Phase 1/2a open-label, dose-escalation, safety and pharmacokinetic study of the companies’ long-lasting, fully-recombinant factor IX Fc fusion protein (rFIXFc) in hemophilia B patients…
No Comments »
Filed under: Pharmacy News
Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito) announced that its U.S. subsidiary Eisai Inc. has received approval from the U.S. Food and Drug Administration (FDA) for Aricept® (generic name: donepezil hydrochloride) 23 mg once daily tablet for the treatment of moderate-to-severe Alzheimer’s disease (AD)…
No Comments »
Filed under: Pharmacy News
Bristol-Myers Squibb Company (NYSE: BMY) presented results from a national survey which found that emotional barriers, such as stigma, fear, denial and shame, and structural barriers, such as lack of knowledge, transportation, and insurance coverage, can prevent people living with HIV/AIDS (PLWHA) from seeking care and treatment…
No Comments »
Filed under: Pharmacy News
GlaxoSmithKline (GSK) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Arixtra (fondaparinux),an anti-clotting drug (antithrombotic) for the treatment of adults with acute symptomatic spontaneous superficial-vein thrombosis (SVT) of the lower limbs without concomitant deep-vein thrombosis…
No Comments »
Filed under: Pharmacy News
The Stop & Shop Supermarket Company has announced a voluntary recall of Nature’s Promise Alfalfa and Zesty Sprouts because they have the potential to be contaminated with listeria monocytogenes.
No Comments »
Filed under: Pharmacy News
